Mark Simon's journey into cancer research began in 2004, building on a lifelong study of plant-based nutrition, holistic health, and natural medicine that dates back to 1982. Driven by a steadfast belief that alternatives to surgery, radiation, and chemotherapy exist through nutritional intervention and natural agents, Mark founded NORI in 2011 to give cancer patients — including those facing cervical cancer — powerful, science-based tools for recovery and long-term management. Under his leadership, NORI has developed the proprietary NORI Protocol, a cycled methionine restriction program that targets universal cancer cell vulnerabilities. Mark oversees all program development, nutraceutical formulation, and client support, ensuring every patient receives individualized care grounded in the latest nutritional oncology research.